We are international
• treatment options TEXT SIZE   


Clinical trials offer patients access to promising new treatments which have not yet been approved. They offer an opportunity to help make new treatments available to all patients by helping to advance science. Patients in clinical trials receive high-quality care and are carefully followed.

Click to view and/or download the slides for Step 10.

If commercially available drugs are not working, then new drugs available only within clinical trials may be recommended. Depending upon the circumstances, a patient may also seek to participate in a later phase clinical trial (e.g., phase III) even from the onset of the disease.

ASH 2011 presentations that address STEP 10


The IMF is pleased to offer a number of ways to help you locate a clinical trial which may be appropriate.

Web sites offer tools to search for clinical trials that may be appropriate for you
ClinicalTrials.gov is a registry of federally and privately supported clinical trials conducted in the United States and around the world. ClinicalTrials.gov gives you information about a trial's purpose, who may participate, locations, and phone numbers for more details. This information should be used in conjunction with advice from health care professionals.
Learn about clinical trials and new medical therapies for treating myeloma, and find trials near you.

National Cancer Institute CancerTrials Search
The National Cancer Institute has an excellent web site, CancerTrials, with basic information about clinical trials and an extensive database of active trials.
TrialCheck® Database
TrialCheck® provides an extensive listing of cooperative group, NCI, and pharmaceutical clinical trials for cancer. You can either view a Full listing of myeloma trials or perform a custom search to find trials in your area or for specific situations

CenterWatch Clinical Trials Information
Lisitngs of open clinical trials. Also includes background information about the clinical trials process, FDA drug approvals, and oncology research center profiles.
Drugs In Development or Recently-Approved
The IMF's Myeloma Matrix lists drugs currently under development and tracks them from discovery to approval.

EmergingMed’s Navigator service enables you to create a detailed profile to see if you match the eligibility requirements of more than 10,000 trials in the United States and Canada.